For more information on the GID BIO Osteoarthritis clinical trial click here

News

The latest GID BIO and cellular therapy news.

Denver Business Journal features GID BIO: “Colorado biotech firm’s new cell therapy could eliminate the need for knee replacements”
Former Yahoo! Chairman, Wall Street Titan Roy J. Bostock Joins GID BIO as Chair
LOUISVILLE, Colo., July 28, 2020 -- Roy J. Bostock, former Chairman of Yahoo!, Vice Chairman of Delta Airlines and a director of Morgan Stanley, has joined the cellular medicine startup GID BIO...
Tulane University School of Medicine announces pivotal clinical trial for patients with knee osteoarthritis
The Tulane University Department of Orthopedics is testing a potential cellular therapy treatment for one of the world’s most common, disabling, painful musculoskeletal conditions, osteoarthritis... 
Physicians: advancing the future of evidence-based cellular therapy could increase quality of life for 14 million US adults suffering from knee osteoarthritis
Over the past three decades cardiothoracic procedures have significantly shifted to minimally invasive techniques with new technology, training of physicians and an ecosystem for workforce development...
Leaders come together for the first time to advance the field of cellular medicine and its treatment of pain and function associated with knee osteoarthritis
A first-of-its kind meeting brought leaders from eight orthopedic, sports medicine, pain management and regenerative medicine advocacy organizations together to discuss advancing cellular medicine in the U.S...
Skip to content